Active Studies
Research Study Eligibility Contact
Atlanta VA Rehab R&D Center for Visual and Neurocognitive Rehabilitation Participant Registry


  • 18 and older


Treating Early Stage Diabetic Retinopathy
  • Age 30-80
  • Diabetes with no detectable vision loss
  • Diabetes with first stages of diabetic retinopathy (i.e. microaneurysms)

Frankie Moore

404.321.6111 ext 126792

Katherine Avery

404.321.6111 ext 201863

Christina Young

404.321.6111 ext 202561

Enhanced Home-Based Exercise Therapy for Peripheral Arterial Disease through Mobile Health and Remote Monitoring: The Smart MOVE Study
  • Confirmed peripheral artery disease (PAD) with symptoms (leg pain)
  • Willingness to participate in a structured exercise/walking program
  • Owns a smart phone with a data plan or access to Wi-Fi

Risha Patel


Brandon Jones

404.321.6111, ext. 202770

The Active AMD Study to Improve Function in Veterans with Age Related Macular Degeneration


  • No regular exercise participation in last 6 months
  • Physician approval to participate in exercise

Medina Bello


*(Affiliate) Multimodal Neuroimaging: Advanced Tracking of Longitudinal Aphasia Recovery

Study Flyer- Stroke Group

Study Flyer - Control Group


  • Male or female age (18-89) who are 2-6 weeks post ischemic stroke
  • English primary language
  • Subjects must be willing to participate and understand the consent


404-321-6111 x207507

rTMS in Alleviating Pain and Co-morbid Symptoms in Gulf War Veterans
  • Age 65 and younger
  • Served in the Gulf War in 1990-1991
  • Have headaches, muscle and joint pain
  • Moderate to severe depression
Carly Ragin


Partnered Dance Aerobic Exercise: A Neuroprotective, Motor and Cognitive Intervention in Parkinson’s Disease


  • Parkinson’s Disease
  • Age 40-89

Cathleen Carroll-Sauer


*(Affiliate) National Adaptive Trial for PTSD related Insomnia (NAP)
  • Age 18-75
  • PTSD related to military service
  • Insomnia
Anil Varughese

404-321-6111, ext. 205068

Intention Treatment for Anomia: Investigating Dose Frequency Effects and Predictors of Treatment Response to Improve Efficacy and Clinical Translation


  • Have aphasia caused by stroke
  • Be 21-89 years old

Anna Ree

404-321-6111 x202561

*Study managed by CVNR affiliate